Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial. (linkinghub.elsevier.com)

Authors: Morand EF … Furie R Journal: The Lancet Published: 2026-05-09 DOI: https://doi.org/10.1016/S0140-6736(26)00463-0